Molecular engineering of HA-based lubricants for articular cartilage
用于关节软骨的 HA 基润滑剂的分子工程
基本信息
- 批准号:10712721
- 负责人:
- 金额:$ 61.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-21 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:AcuteAdhesionsAdhesivesAnimal ModelArchitectureAtomic Force MicroscopyBone TissueCartilageCartilage injuryChargeClinicClinicalDegenerative polyarthritisDeteriorationDevelopmentElectrostaticsEngineeringEnsureExhibitsExtracellular MatrixFamily suidaeFormulationFrictionGoalsHistologicHyaluronic AcidImageIndividualInjuryInterventionIntra-Articular InjectionsJointsLiquid substanceLubricantsLubricationLysineMeasurementMechanicsModelingMolecularMolecular WeightMonitorMovementOperative Surgical ProceduresOutcomePainPropertyPyrimidinonesResearchRoleSalineSlideSurfaceSynovial FluidSynovial MembraneTimeTissuesTraumaTraumatic ArthropathyUnited StatesWeight-Bearing stateanterior cruciate ligament injuryanterior cruciate ligament reconstructionarticular cartilagecartilage degradationchondroprotectiondesignhealingimprovedimproved outcomein vivoinflammatory markerjoint injurylubricinnovelnovel therapeutic interventionpreventrepairedsuccess
项目摘要
ABSTRACT
Altered lubrication of articular cartilage following joint injury increases friction between the sliding cartilage
surfaces, leads to deterioration of cartilage, and hastens the development of osteoarthritis (OA). OA due to joint
injury, termed as post-traumatic osteoarthritis (PTOA), is estimated to account for at least 12% of all OA cases
in the United States and approximately half of the individuals with an anterior cruciate ligament (ACL) injury
develop PTOA regardless of the ACL reconstruction. Replenishing the synovial fluid and thereby restoring the
articular cartilage lubrication has been demonstrated to benefit the joint. The overarching goal of the proposed
study is to investigate the potential of cartilage-adhering, self-healing hyaluronic acid molecules to prevent or
delay the degeneration of articular cartilage, and thereby osteoarthritis, following injury or trauma. The
molecularly engineered HA-based lubricants are designed to integrate the function of both hyaluronic acid and
lubricin, two key components of the synovial fluid, while exhibiting self-repairing ability. The self-healing
properties are incorporated to ensure both long-term retention and adaptability of the lubricant within the
mechanically active joint, while the cartilage adhering properties are expected to improve boundary lubrication.
We hypothesize that the dynamic cartilage-adhering molecules that integrate the molecular features of HA and
lubricin and simultaneously exhibit self-healing properties will protect the articular cartilage and prevent or slow
down the progression of PTOA. Towards this, we will: (i) develop cartilage-adhering, self-healing HA molecules
and determine the effect of molecular architecture-lubrication function relationship, (ii) determine the effect of the
molecular architecture of the proposed novel HA-based lubricants on chondroprotection by using a joint-on-chip
platform, and (iii) determine the effect of these lubricants on mitigating the development of post-traumatic
osteoarthrits. The proposed studies will enable a new paradigm in which intra-articular injection of self-healing
HA-bottle brush molecules could be an important treatment following acute injury to ameliorate or delay PTOA,
or they could be used as an adjunct after surgical repair to improve the outcome.
抽象的
关节损伤后关节软骨的润滑改变会增加滑动软骨之间的摩擦
表面,导致软骨恶化,并加快骨关节炎(OA)的发展。 OA由于关节
据估计,受伤被称为创伤后骨关节炎(PTOA),估计占所有OA病例的12%
在美国和大约一半的患有前交叉韧带(ACL)损伤的个体
开发PTOA,无论ACL重建如何。补充滑液,从而恢复
已证明关节软骨润滑有益于关节。拟议的总体目标
研究是为了研究软骨粘附的自我修复透明质酸分子的潜力,以预防或
受伤或创伤后,延迟关节软骨的变性,从而延迟骨关节炎。这
分子设计的基于HA的润滑剂旨在整合透明质酸和
润滑剂是滑液的两个关键成分,同时表现出自我修复能力。自我修复
合并性能以确保润滑剂在
机械活动的关节,而软骨粘附特性则有望改善边界润滑。
我们假设动态软骨粘附的分子整合了HA和HA的分子特征
润滑剂和同时表现出自我修复特性将保护关节软骨并预防或缓慢
向下PTOA的进展。在此方面,我们将:(i)发展软骨粘附的,自我修复的HA分子
并确定分子结构润滑功能关系的影响,(ii)确定
拟议的新型基于HA的润滑剂的分子结构是在软骨保护方面,通过使用片上的关节芯片
平台和(iii)确定这些润滑剂对缓解创伤后发展的影响
骨关节炎。拟议的研究将实现一个新的范式,其中关节内注射自我修复
HA瓶刷分子可能是急性损伤以改善或延迟PTOA后的重要治疗方法,
否则它们可以在手术修复后用作辅助手段以改善结果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shyni Varghese其他文献
Shyni Varghese的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shyni Varghese', 18)}}的其他基金
Localization of adenosine to promote fracture healing
腺苷定位促进骨折愈合
- 批准号:
10461465 - 财政年份:2022
- 资助金额:
$ 61.19万 - 项目类别:
Localization of adenosine to promote fracture healing
腺苷定位促进骨折愈合
- 批准号:
10700832 - 财政年份:2022
- 资助金额:
$ 61.19万 - 项目类别:
Modulation of local adenosine signaling to attenuate fracture pain
调节局部腺苷信号传导以减轻骨折疼痛
- 批准号:
10543700 - 财政年份:2021
- 资助金额:
$ 61.19万 - 项目类别:
Modulation of local adenosine signaling to attenuate fracture pain
调节局部腺苷信号传导以减轻骨折疼痛
- 批准号:
10390489 - 财政年份:2021
- 资助金额:
$ 61.19万 - 项目类别:
Modulation of local adenosine signaling to attenuate fracture pain
调节局部腺苷信号传导以减轻骨折疼痛
- 批准号:
10614931 - 财政年份:2021
- 资助金额:
$ 61.19万 - 项目类别:
Modulation of local adenosine signaling to attenuate fracture pain
调节局部腺苷信号传导以减轻骨折疼痛
- 批准号:
10227375 - 财政年份:2021
- 资助金额:
$ 61.19万 - 项目类别:
Modulation of local adenosine signaling to attenuate fracture pain
调节局部腺苷信号传导以减轻骨折疼痛
- 批准号:
10812649 - 财政年份:2021
- 资助金额:
$ 61.19万 - 项目类别:
Bioinspired Synthetic Grafts for Bone Regeneration
用于骨再生的仿生合成移植物
- 批准号:
9551215 - 财政年份:2017
- 资助金额:
$ 61.19万 - 项目类别:
Adenosine A2B Receptor in Bone Health and Osteoporosis
腺苷 A2B 受体在骨骼健康和骨质疏松症中的作用
- 批准号:
9551206 - 财政年份:2017
- 资助金额:
$ 61.19万 - 项目类别:
相似国自然基金
载Pexidartinib的纳米纤维膜通过阻断CSF-1/CSF-1R通路抑制巨噬细胞活性预防心脏术后粘连的研究
- 批准号:82370515
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
促细胞外囊泡分泌的绒毛膜纳米纤维仿生培养体系的构建及其在宫腔粘连修复中的应用研究
- 批准号:32301204
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
泛素连接酶SMURF2通过SMAD6-COL5A2轴调控宫腔粘连纤维化的分子机制研究
- 批准号:82360301
- 批准年份:2023
- 资助金额:31 万元
- 项目类别:地区科学基金项目
负载羟基喜树碱的双层静电纺纳米纤维膜抑制肌腱粘连组织增生的作用和相关机制研究
- 批准号:82302691
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
活血通腑方调控NETs干预术后腹腔粘连组织纤维化新途径研究
- 批准号:82374466
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
相似海外基金
Red blood cell ATP export and transfusion in sepsis
脓毒症中红细胞 ATP 输出和输血
- 批准号:
10584768 - 财政年份:2023
- 资助金额:
$ 61.19万 - 项目类别:
Reagentless Sensor Technologies For Continuous Monitoring of Heart Failure Biomarkers
用于连续监测心力衰竭生物标志物的无试剂传感器技术
- 批准号:
10636089 - 财政年份:2023
- 资助金额:
$ 61.19万 - 项目类别:
Novel strategies to accelerate repair of drug-induced hepatotoxicity
加速修复药物引起的肝毒性的新策略
- 批准号:
10718314 - 财政年份:2023
- 资助金额:
$ 61.19万 - 项目类别:
Biomolecule releasing adhesive for cell-mediated labral repair
用于细胞介导的盂唇修复的生物分子释放粘合剂
- 批准号:
10736334 - 财政年份:2023
- 资助金额:
$ 61.19万 - 项目类别:
Altered hyaluronan deposition by bronchial epithelial cells contributes to inflammation during respiratory syncytial virus infection
支气管上皮细胞改变的透明质酸沉积导致呼吸道合胞病毒感染期间的炎症
- 批准号:
10418432 - 财政年份:2022
- 资助金额:
$ 61.19万 - 项目类别: